275 results on '"Wang, Hui‐Ching"'
Search Results
2. Prognostic mutation signature would serve as a potential prognostic predictor in patients with diffuse large B-cell lymphoma
3. Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)
4. Clinical practice consensus for the diagnosis and management of melanoma in Taiwan
5. Prevention and management of esophageal stricture after esophageal ESD: 10 years of experience in a single medical center
6. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway
7. Comparison of a novel lateral-flow device to galactomannan assay at different time periods for detections of invasive aspergillosis
8. Growth regulated oncogene-α contribute to EMT/MMPs pathway by binding its receptors in head and neck squamous cell carcinoma
9. Investigating the Pulmonary Host Response of Acinetobacter baumannii Infection-Associated Pneumonia by Metagenomic Next-Generation Sequencing.
10. BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer
11. Chromatin Remodeling-Related PRDM1 Increases Stomach Cancer Proliferation and Is Counteracted by Bromodomain Inhibitor
12. Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society registry database.
13. The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer Cohort
14. High G9a Expression in DLBCL and Its Inhibition by Niclosamide to Induce Autophagy as a Therapeutic Approach
15. Distinct clinical characteristics of paroxysmal nocturnal hemoglobinuria in patients in Southern Taiwan: A multicenter investigation
16. An Explicit and Implicit Tailored Finite Point Method for Option Pricing Simulation
17. The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
18. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
19. The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan
20. Growth Regulated Oncogene-α Upregulates TNF-α and COX-2 and Activates NOD1/RIPK2 mediated-MAPK Pathway in Head and Neck Squamous Cell Carcinoma
21. Prevention and management of esophageal stricture after esophageal ESD: 10 years of experience in a single medical center
22. Using Molecular Dynamics Simulation and Parallel Computing Technique of the Deposition of Diamond-Like Carbon Thin Films
23. Fatal invasive aspergillosis: a rare co‐infection with an unexpected image presentation in a patient with dengue shock syndrome
24. Evaluation of the Time-Varying Effect of Prognostic Factors on Survival in Ovarian Cancer
25. Automatic extraction of face contours in images and videos
26. Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and Autophagy
27. A real-world study of prognostic factors and risk-stratification model from Taiwanese patients with recurrent or metastatic head and neck squamous cell carcinoma treated with cetuximab containing regimen.
28. Revisit of the Association between Cytomegalovirus Infection and Invasive Fungal Infection after Allogeneic Hematopoietic Stem Cell Transplantation: A Real-World Analysis from a High CMV Seroprevalence Area
29. An Explicit and Implicit Tailored Finite Point Method for Option Pricing Simulation
30. Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphoma.
31. The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern Taiwan
32. Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer
33. Is it reasonable for the use of Rh‐ee blood? A hospital‐based survey from a southern medical center in Taiwan
34. Effect of Tumor Microenvironment and Angiogenesis on Clinical Outcomes of Primary Central Nervous System Lymphoma
35. Low Geriatric Nutritional Risk Index Is Associated with Poorer Prognosis in Elderly Diffuse Large B-Cell Lymphoma Patients Unfit for Intensive Anthracycline-Containing Therapy: A Real-World Study
36. Progression Risk Score Estimation Based on Immunostaining Data in Oral Cancer Using Unsupervised Hierarchical Clustering Analysis: A Retrospective Study in Taiwan
37. Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
38. Multi-Threshold Level Set Model for Image Segmentation
39. Corrigendum to: “BMI1-KLF4 axis deficiency improves responses to neoadjuvant concurrent chemoradiotherapy in patients with rectal cancer” [Radiother Oncol 149 (2020) 249–258]
40. Application of the Interaction between Tissue Immunohistochemistry Staining and Clinicopathological Factors for Evaluating the Risk of Oral Cancer Progression by Hierarchical Clustering Analysis: A Case-Control Study in a Taiwanese Population
41. Immunohistochemical Expression of Five Protein Combinations Revealed as Prognostic Markers in Asian Oral Cancer
42. Silencing DNA Polymerase β Induces Aneuploidy as a Biomarker of Poor Prognosis in Oral Squamous Cell Cancer
43. The Overall Efficacy and Outcomes of Metronomic Tegafur-Uracil Chemotherapy on Locally Advanced Head and Neck Squamous Cell Carcinoma: A Real-World Cohort Experience
44. Using Molecular Dynamics Simulation and Parallel Computing Technique of the Deposition of Diamond-Like Carbon Thin Films
45. Periodic fever as the manifestation of primary Sjogren’s syndrome: a case report and literature review
46. Modified gemcitabine, S-1, and leucovorin combination for patients with newly diagnosed locally advanced or metastatic pancreatic adenocarcinoma: A multi-center retrospective study in Taiwan
47. Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
48. Consistent administration of cetuximab is associated with favorable outcomes in recurrent/metastatic head and neck squamous cell carcinoma in an endemic carcinogen exposure area: a retrospective observational study
49. Calreticulin mutation survey by high resolution melting method associated with unique presentations in essential thrombocythemic patients
50. Hepatitis B virus surface antigen interacts with acid alpha-glucosidase and alters glycogen metabolism
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.